Matches in SemOpenAlex for { <https://semopenalex.org/work/W4236030507> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4236030507 abstract "Preeclamptic patients display elevated placenta-derived soluble Fms-like tyrosine kinase-1 (sFlt-1) and endoglin levels, and decreased placental growth factor (PlGF) levels. Proton pump inhibitors (PPIs) decrease trophoblast sFlt-1 and endoglin secretion in vitro. PPIs are used during pregnancy, to combat reflux disease. Here we investigated whether PPIs affect sFlt-1 in women with confirmed/suspected preeclampsia, making use of a prospective cohort study involving 430 women. Of these women, 40 took PPIs (6 esomeprazole, 32 omeprazole and 2 pantoprazole) for 8-45 (median 29) days before sFlt-1 measurement. Measurements were only made once, at study entry between weeks 20-41 (median 33 weeks). PPI use associated with lower sFlt-1 levels, with no change in PlGF levels, both when compared to all non-PPI users, and to 80 gestational age-matched controls selected from the non-PPI users. No sFlt-1/PlGF alterations were observed in women using ferrous fumarate or macrogol, while, as expected, women using antihypertensive medication displayed higher sFlt-1 levels and/or lower PlGF levels. The PPI use-associated decrease in sFlt-1 was independent of the application of antihypertensive drugs and also occurred when restricting our analysis to patients with hypertensive disease of pregnancy at study entry. PPI users displayed more cases with preexisting proteinuria, less gestational hypertension, and a lower number of neonatal sepsis cases. Finally, their plasma endoglin and endothelin-1 levels were lower, while sFlt-1 levels correlated positively with both. In conclusion, PPI use associates with low sFlt-1, endoglin, and endothelin-1 levels, warranting prospective trials to investigate the therapeutic potential of PPIs in preeclampsia." @default.
- W4236030507 created "2022-05-12" @default.
- W4236030507 creator A5002859700 @default.
- W4236030507 creator A5038074463 @default.
- W4236030507 creator A5046295598 @default.
- W4236030507 creator A5085817090 @default.
- W4236030507 date "2017-09-01" @default.
- W4236030507 modified "2023-09-27" @default.
- W4236030507 title "Abstract 040: Low Soluble Fms-like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors" @default.
- W4236030507 doi "https://doi.org/10.1161/hyp.70.suppl_1.040" @default.
- W4236030507 hasPublicationYear "2017" @default.
- W4236030507 type Work @default.
- W4236030507 citedByCount "0" @default.
- W4236030507 crossrefType "journal-article" @default.
- W4236030507 hasAuthorship W4236030507A5002859700 @default.
- W4236030507 hasAuthorship W4236030507A5038074463 @default.
- W4236030507 hasAuthorship W4236030507A5046295598 @default.
- W4236030507 hasAuthorship W4236030507A5085817090 @default.
- W4236030507 hasConcept C10205521 @default.
- W4236030507 hasConcept C126322002 @default.
- W4236030507 hasConcept C134018914 @default.
- W4236030507 hasConcept C167734588 @default.
- W4236030507 hasConcept C2776871010 @default.
- W4236030507 hasConcept C2777025900 @default.
- W4236030507 hasConcept C2777218350 @default.
- W4236030507 hasConcept C2778376644 @default.
- W4236030507 hasConcept C2779184299 @default.
- W4236030507 hasConcept C2779234561 @default.
- W4236030507 hasConcept C28328180 @default.
- W4236030507 hasConcept C54355233 @default.
- W4236030507 hasConcept C6061869 @default.
- W4236030507 hasConcept C71924100 @default.
- W4236030507 hasConcept C86803240 @default.
- W4236030507 hasConcept C90924648 @default.
- W4236030507 hasConceptScore W4236030507C10205521 @default.
- W4236030507 hasConceptScore W4236030507C126322002 @default.
- W4236030507 hasConceptScore W4236030507C134018914 @default.
- W4236030507 hasConceptScore W4236030507C167734588 @default.
- W4236030507 hasConceptScore W4236030507C2776871010 @default.
- W4236030507 hasConceptScore W4236030507C2777025900 @default.
- W4236030507 hasConceptScore W4236030507C2777218350 @default.
- W4236030507 hasConceptScore W4236030507C2778376644 @default.
- W4236030507 hasConceptScore W4236030507C2779184299 @default.
- W4236030507 hasConceptScore W4236030507C2779234561 @default.
- W4236030507 hasConceptScore W4236030507C28328180 @default.
- W4236030507 hasConceptScore W4236030507C54355233 @default.
- W4236030507 hasConceptScore W4236030507C6061869 @default.
- W4236030507 hasConceptScore W4236030507C71924100 @default.
- W4236030507 hasConceptScore W4236030507C86803240 @default.
- W4236030507 hasConceptScore W4236030507C90924648 @default.
- W4236030507 hasIssue "suppl_1" @default.
- W4236030507 hasLocation W42360305071 @default.
- W4236030507 hasOpenAccess W4236030507 @default.
- W4236030507 hasPrimaryLocation W42360305071 @default.
- W4236030507 hasRelatedWork W13258810 @default.
- W4236030507 hasRelatedWork W14443591 @default.
- W4236030507 hasRelatedWork W1507922 @default.
- W4236030507 hasRelatedWork W220526 @default.
- W4236030507 hasRelatedWork W2941215 @default.
- W4236030507 hasRelatedWork W345235 @default.
- W4236030507 hasRelatedWork W5647909 @default.
- W4236030507 hasRelatedWork W6113516 @default.
- W4236030507 hasRelatedWork W6203181 @default.
- W4236030507 hasRelatedWork W7075613 @default.
- W4236030507 hasVolume "70" @default.
- W4236030507 isParatext "false" @default.
- W4236030507 isRetracted "false" @default.
- W4236030507 workType "article" @default.